Investor Veto Rights: When Protective Provisions Become Operational Control

What are investor veto rights for?

An investor holding a minority stake cannot outvote the founders. Protective provisions give that investor a veto over a defined set of matters, so the company cannot simply resolve away the value of their holding by issuing cheap shares, altering the rights attaching to their class, or selling the business to a related party.

That purpose is legitimate, and a founder arguing for no protective provisions at all is arguing against the basic structure of venture investment. The negotiation is about scope, not existence.

It helps to know what company law already provides. Under Section 114 of the Companies Act, 2013, a special resolution needs votes in favour of at least three times the votes against. Many important decisions, including altering the articles under Section 14, need a special resolution. An investor with more than 25% of the votes can block those by law, whatever the SHA says. Reserved matters add a veto on top of that, sometimes for investors holding much less.

The reasonable core

The following items protect the value and rights of the investor's shares, rather than governing day-to-day business. Most founders accept them, and pushing back on them uses negotiating capital better spent elsewhere.

• Issuing new shares or instruments convertible into shares, and changing the capital structure.
• Altering the rights, preferences or privileges attaching to any class of shares.
• Winding up, merger, sale of the company or of substantially all its assets.
• Amending the articles or the shareholders agreement.
• Related-party transactions, which also engage Section 188 of the Companies Act, 2013 separately.
• Declaring dividends or altering the dividend policy.
• Changing the size or composition of the board, or the auditors.

When does a protective provision become operational control?

The items to look at carefully are the operational ones. Approving the annual budget, hiring or terminating senior employees, changing the business plan, entering contracts above a stated value, incurring borrowing above a threshold, opening or closing a line of business, or setting salaries above a level.

Individually each can be justified. Collectively they convert a protective provision into a management veto, and the practical effect is that the company cannot move without an investor sign-off on decisions the board should be making. The question to ask of each line is whether it protects the investment or governs the business.

The details that decide how it feels in practice

Two mechanics matter more than the list. First, who holds the veto. A single consent right exercisable by investors holding a majority of the preference shares is manageable. Separate individual vetoes for each of four investors means any one of them can block, and coordinating four sign-offs on a routine matter is a genuine operational cost.

Second, how thresholds are expressed. A consent requirement for contracts above ₹1 crore is restrictive for a company at ₹10 crore of revenue and irrelevant at ₹500 crore. Tying thresholds to a percentage of revenue or to the approved budget, rather than to a fixed rupee figure, keeps the provision proportionate as you grow.

A third mechanic is timing. A consent right with no response deadline lets an investor block by silence. Founders who have lived through a slow consent process on a hiring decision or a vendor contract tend to value a deemed-consent clause more than any single item on the list.

Board approval or investor consent: is there a difference?

Yes, and it is significant. When a matter goes to the board, it is decided by directors, who under Section 166 of the Companies Act, 2013 must act in good faith to promote the objects of the company for the benefit of its members as a whole. An investor nominee director has those duties too. When a matter goes to investor consent, the investor decides as a shareholder in its own interest.

That is why moving operational items from investor consent to board approval is the most useful single change a founder can negotiate. The investor still has a voice through its nominee director, but the decision is taken by a body whose members owe duties to the company. A common middle ground is board approval that must include the affirmative vote of the investor director, limited to a short list of items.

A worked example: one hire, four sign-offs

A Pune SaaS company with ₹12 crore of annual revenue has raised two rounds. Its SHA requires the prior written consent of each of three investors for any hire with annual cost above ₹40 lakh, and for any contract above ₹1 crore. The company wants to hire a head of sales at ₹55 lakh and sign a ₹1.2 crore annual cloud contract, both within the board-approved budget.

Three consents are needed for each decision. One investor's partner is travelling and replies in three weeks. The candidate accepts another offer. The cloud provider's discount lapses. Nothing in either decision affected the investors' share rights, and both were already in the budget the board approved.

The fix in the next round is straightforward: matters within the approved annual budget need no further consent; consent is given by investors holding a majority of the investor shares rather than each investor; the hiring threshold applies only to CXO roles; contract thresholds are set at 15% of the previous year's revenue; and consent is deemed given after ten business days. None of these changes weakens the investors' protection against dilution or restructuring.

How should reserved matters work across several rounds?

Each round typically brings a new lead investor with its own template, and lists accumulate. By Series B, a company can have reserved matters in an amended SHA, a side letter and the articles, with slightly different wording in each. That is a recipe for disputes about whether consent was needed at all.

At each round, ask counsel to consolidate everything into one restated SHA and one set of amended articles, with a single reserved matters list and a single consenting body, usually investors holding a defined majority of all investor shares. Earlier investors whose stake has fallen below a threshold should lose their separate consent rights at that point.

Sample wording to propose

Two clauses do most of the work in practice. For deemed consent:

"If the Investor Majority does not respond to a written request for consent, accompanied by reasonable supporting information, within ten Business Days of receipt, consent shall be deemed to have been given."

For a fall-away:

"The rights of the Investors under this Clause shall cease if the Investors together hold less than [5]% of the share capital on a fully diluted basis, or on completion of a Qualified IPO."

Ask also for the reserved matters list to be reproduced in the articles, so that the company's obligations are clear and there is one list rather than several inconsistent ones.

Can veto rights be renegotiated later?

Yes, but only with the investor's agreement, and the moments when that agreement is realistic are limited. The two natural windows are the next funding round, when a new lead investor often wants a cleaner structure and earlier investors expect some changes, and a period of strong performance, when an investor has less reason to resist a reasonable request.

Outside those windows, an SHA amendment needs the parties whose consent the SHA requires, usually including the investors whose rights are being reduced, and any corresponding change to the articles needs a special resolution. Founders therefore get one real chance to shape the list, which is at the term sheet. Treat the reserved matters schedule as a core economic term, read it line by line, and ask for the changes before signing rather than hoping to revisit them.

What to negotiate

• Move operational items from investor consent to board approval, where the investor has a director anyway.
• Consolidate individual vetoes into a single consent of investors holding a defined majority.
• Express thresholds as percentages or by reference to the approved budget rather than fixed amounts.
• Add a deemed-consent mechanism if no response is received within a stated number of business days.
• Allow matters within an approved budget or business plan to proceed without further consent.
• Provide for the list to fall away below a shareholding threshold, on a later financing round or on listing.
• Ask the investor to explain, for each operational item, what risk it protects against. Items with no clear answer are usually the ones the investor will concede.